Safety and Performance Using Legion™ CR Oxinium and CoCr Femoral Implants Combined With Legion™/Genesis™ II XLPE High Flex Tibial Inserts

Exclusion Criteria

• •1. Subject had Body Mass Index (BMI) \> 40 at time of surgery.
• •2. Subject received the Legion™ CR Femoral Implant with Legion™/Genesis™ II XLPE Hi-flex Tibial Insert as a revision surgery.
• •3. Subject has a condition that may interfere with the TKA survival or outcome (e.g. Paget's or Charcot's disease, vascular insufficiency, muscular atrophy, uncontrolled diabetes, moderate to severe renal insufficiency or neuromuscular disease).
• •4. Subject has a known allergy to one or more of its components of the study device.
• •5. Subject, in the opinion of the Principal Investigator (PI), has an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study including mental illness, mental retardation, drug or alcohol abuse.
• •6. Subject is entered in another drug, biologic, or device study or has been treated with an investigational product in the past 30 days.
• •7. Subject is known to be at risk for loss to follow-up, or failure to return for scheduled visits.